All In MedTech

Device Trial Radar · NCT05245812

Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy

Safety and Feasibility of Robotic Single-port (SP) Nipple Sparing Mastectomy: A Single Institution, Single Arm Pilot Trial

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

180

Planned (sponsor's estimate)

Start

Mar 8, 2022

Primary completion

Feb 2027

Study completion Feb 2027

Sponsor

Lead sponsor
Deborah Farr, MDAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 18, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a single arm, single-center, prospective clinical trial designed to track the peri, post-operative and oncologic outcomes when utilizing the da-Vinci single port (SP) robotic platform to perform robotic nipple sparing mastectomy (rNSM) and immediate breast reconstruction with tissue expanders/implants and acellular dermal matrix (ADM - Alloderm), for patients with breast cancer as well as those with a high risk for breast cancer. Safety and feasibility measures will be measured as primary outcome measures. Oncological and patient satisfaction outcome measures will be measured. Our hypothesis is that SPr-NSM is equal to open NSM in terms of safety, feasibility and oncological outcomes with improved patient satisfaction as measured by nipple sensation and patient reported outcomes.

Conditions

  • Breast Cancer
  • High Risk of Breast Cancer

Interventions

  • da Vinci SP Surgical SystemDevice

    This is a software-controlled, electro- mechanical system designed for surgeons to perform single port minimally invasive surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants who complete single port nipple sparing mastectomy (SPrNSM)Time frame: Date of surgery (Day 1)
  2. Incidence of perioperative complicationsTime frame: 30 days following surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • UT Southwestern

    Dallas, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.